Discovery of potent and selective rhodanine type IKK beta inhibitors by hit-to-lead strategy
- Authors
- Song, Hyeseung; Lee, Yun Suk; Roh, Eun Joo; Seo, Jae Hong; Oh, Kwang-Seok; Lee, Byung Ho; Han, Hogyu; Shin, Kye Jung
- Issue Date
- 1-9월-2012
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Keywords
- IKK beta inhibitor; NF-kappa B; TNF alpha; Reumatoid athritis; Hit-to-lead
- Citation
- BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.22, no.17, pp.5668 - 5674
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Volume
- 22
- Number
- 17
- Start Page
- 5668
- End Page
- 5674
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/107477
- DOI
- 10.1016/j.bmcl.2012.06.088
- ISSN
- 0960-894X
- Abstract
- Regulation of NF-kappa B activation through the inhibition of IKK beta has been identified as a promising target for the treatment of inflammatory and autoimmune disease such as rheumatoid arthritis. In order to develop novel IKK beta inhibitors, we performed high throughput screening toward around 8000 library compounds, and identified a hit compound containing rhodanine moiety. We modified the structure of hit compound to obtain potent and selective IKK beta inhibitors. Throughout hit-to-lead studies, we have discovered optimized compounds which possess blocking effect toward NF-kappa B activation and TNF alpha production in cell as well as inhibition activity against IKK beta. Among them, compound 3q showed the potent inhibitory activity against IKK beta, and excellent selectivity over other kinases such as p38 alpha, p38 beta, JNK1, JNK2, and JNK3 as well as IKK alpha. (C) 2012 Elsevier Ltd. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Science > College of Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.